Compugen Ltd
Clinical trials sponsored by Compugen Ltd, explained in plain language.
-
New antibody COM701 aims to keep ovarian cancer at bay
Disease control Recruiting nowThis clinical trial tests whether the experimental antibody COM701 can delay the return of ovarian cancer in people whose cancer has come back but still responds to platinum chemotherapy. About 60 participants will receive COM701 or a placebo every three weeks as maintenance ther…
Phase: PHASE1, PHASE2 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug COM503 enters first human trial for advanced cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called COM503, alone or with another drug zimberelimab, in 200 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose. It is a first-in-human study, so effe…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC